Completed

Effects of Combined Alcohol and Nitrous Oxide Intake

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

30% Nitrous oxide

+ 0 g/Kg ethanol

+ 0.25 g/Kg ethanol

DrugOther
Who is being recruted

Narcotic-Related Disorders+2

+ Mental Disorders

+ Opioid-Related Disorders

See all eligibility criteria
How is the trial designed

Placebo-Controlled
Interventional
Study Start: January 1997
See protocol details

Summary

Principal SponsorUniversity of Chicago
Last updated: January 27, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: January 1, 1997

Actual date on which the first participant was enrolled.

The purpose of this study is to determine the effects of combined alcohol and nitrous oxide intake on mood, psychomotor performance, and the pain response in healthy volunteers.

Official TitleEffects of Combined Alcohol and Nitrous Oxide Intake
NCT00000263
Principal SponsorUniversity of Chicago
Last updated: January 27, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

11 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Healthy volunteers allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Narcotic-Related DisordersMental DisordersOpioid-Related DisordersSubstance-Related DisordersChemically-Induced Disorders

Criteria

Please contact site for information.

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

3 intervention groups are designated in this study

33.333% chance of being blinded to the placebo group

Treatment Groups

Group I

Placebo

Group II

Active Comparator

Group III

Active Comparator

Study Objectives

Primary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Suspended

University of Chicago, Anesthesia & Critical Care

Chicago, United StatesOpen University of Chicago, Anesthesia & Critical Care in Google Maps
CompletedOne Study Center